Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Phase 3    symbols : BAX    save search

Xenetic Biosciences Announces Positive Phase 1 Clinical Data for PulmoXen(TM) for Treatment of Cystic Fibrosis
Published: 2014-04-07 (Crawled : 07:00) - globenewswire.com
BAX | $40.93 -0.22% 0.0% 3 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
XBIO | $3.78 -1.82% 7.32% 540 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

treatment fibrosis phase 1 positive phase 3 phase 2 cystic fibrosis
Merrimack Pharmaceuticals Announces Initiation of Phase 1 Clinical Study of MM-398 for Brain Cancer
Published: 2014-11-06 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.71 -0.14% -0.07% 560 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BAX | $40.93 -0.22% 0.0% 3 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

phase 1 cancer brain cancer phase 3 phase 2 train
Merrimack Pharmaceuticals Presents Additional Analyses of Phase 3 MM-398 NAPOLI-1 Study at the American Society of Clinical Oncology (ASCO) 2015 Gastrointestinal Cancers Symposium
Published: 2015-01-20 (Crawled : 12:20) - globenewswire.com
MACK 4 | $14.71 -0.14% -0.07% 560 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
BAX | $40.93 -0.22% 0.0% 3 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

test cancer gastrointestinal phase 3 symposium
Xenetic Biosciences Announces Positive Phase 1 Clinical Results for PSA-Oxyntomodulin for the Treatment of Type II Diabetes and Obesity
Published: 2014-05-12 (Crawled : 00:20) - globenewswire.com
BAX | $40.93 -0.22% 0.0% 3 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
XBIO | $3.78 -1.82% 7.32% 540 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

diabetes treatment obesity phase 1 positive results phase 3 phase 2
Gainers vs Losers
61% 39%

Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M twitter stocktwits trandingview |

BHIL | $0.1793 -4.37% 19.24% 340K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K twitter stocktwits trandingview |

CI | $352.28 -0.11% 13.53% 2 twitter stocktwits trandingview |
Health Services

CIG.C | $2.89 -1.37% 12.8% 2.3K twitter stocktwits trandingview |
n/a

BMTX 4 | $1.545 0.98% 10.03% 2.5K twitter stocktwits trandingview |
Information

TAL | $12.26 0.57% 9.22% 12M twitter stocktwits trandingview |
Consumer Services

MTH | $154.69 -2.21% 7.56% 64 twitter stocktwits trandingview |
Consumer Durables

ASXC | $0.243 -2.41% 7.0% 1.1M twitter stocktwits trandingview |
Manufacturing

IHT P | $1.3712 0.82% 6.48% 0 twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.